间三氟甲基苯丙酸乙酯 | 70311-33-0

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 间三氟甲基苯丙酸乙酯
• 英文名称: ethyl 3-(3-trifluoromethylphenyl)-propionate
• 英文别名: 3-(3-(trifluoromethyl)phenyl)propanoic acid ethyl ester；ethyl 3-[3-(trifluoromethyl)phenyl]propanoate；ethyl 3-[3-(trifluoromethyl)phenyl]propionate；Ethyl 3-(3-trifluoromethylphenyl)propionate；Ethyl 3-(3-(trifluoromethyl)phenyl)propanoate
• CAS: 70311-33-0
• 化学式: C₁₂H₁₃F₃O₂
• 分子量: 246.229
• InChiKey: OUHPHSYPKKLTKJ-UHFFFAOYSA-N

物化性质

• 沸点：
  252.1±35.0 °C(Predicted)
• 密度：
  1.179±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  间三氟甲基苯丙酸乙酯 在 一水合肼 作用下， 以 乙醇 为溶剂， 以81%的产率得到3-[3-(trifluoromethyl)phenyl]propanohydrazide
  参考文献：
  名称：

  GSK-3BETAINHIBITOR

  摘要：

  为了提供一种含有噁二唑化合物或其盐或其前药的GSK-3β抑制剂，用作GSK-3β相关病理或疾病的预防或治疗剂，本发明提供了一种含有由以下式（I）表示的化合物的GSK-3β抑制剂： 其中每个符号如规范中定义，或其盐或其前药。

  公开号：

  US20100069381A1
• 作为产物：
  描述：

  ethyl 3-trifluoromethylcinnamate 在 platinum(IV) oxide 氢气 作用下， 以 乙醇 为溶剂， 生成 间三氟甲基苯丙酸乙酯
  参考文献：
  名称：

  Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils.

  摘要：

  A series of 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils were synthesized and tested for inhibition of murine liver uridine phosphorylase (UrdPase). Inhibitors of UrdPase are reported to enhance the chemotherapeutic utility of 5-fluoro-2'-deoxyuridine and 5-fluorouracil and to ameliorate zidovudine-induced anemia in animal models. We prepared a series of 5-aryl-substituted analogues of 5-benzylacyclouridine (BAU), a good inhibitor of UrdPase (IC50 of 0.46 mu M), to develop a compound with enhanced potency and improved pharmacokinetics. The first phase of structure-activity relationship studies on a series of 32 aryl-substituted 5-benzyluracils found several 5-(3-alkoxybenzyl) analogues of 5-benzyluracil with enhanced potency. The acyclovir side chain, the (2-hydroxyethoxy)methyl group, was substituted on the more potent aryl-substituted 5-benzyluracils. The two most potent compounds, 10y (3-propoxy) and 10dd (3-sec-butoxy), were inhibitors of UrdPase with IC(50)s of 0.047 and 0.027 mu M, respectively. Six compounds were tested in vivo for effects on steady-state concentrations of circulating uridine in rats. Plasma uridine levels were elevated 3-9-fold by compound levels that ranged from 8 to 50 mu M.

  DOI：

  10.1021/jm00019a015

文献信息

• Base directed palladium catalysed Heck arylation of acrolein diethyl acetal in water
  作者：Walid Al-Maksoud、Stéphane Menuel、Mohamad Jahjah、Eric Monflier、Catherine Pinel、Laurent Djakovitch

  DOI：10.1016/j.apcata.2013.10.004

  日期：2014.1

  The selective Heck arylation of acrolein diethyl acetal catalysed by [Pd(NH3)4]Cl2 in the presence of RAME-β-CD in water as solvent is described. Depending on the base (i.e. NaOAc or HN(i-Pr)2) good to high selectivity's towards, respectively, the cinnamaldehydes 2 or the 3-arylpropionic esters 1 were achieved. The results support that depending on the base different palladium intermediate complexes

  描述了在存在RAME-β-CD的水中作为溶剂的[Pd（NH 3）4 ] Cl 2催化的丙烯醛乙缩醛的选择性Heck芳基化。取决于对肉桂醛2或3-芳基丙酸酯1分别具有良好至高选择性的碱（即NaOAc或HN（i- Pr）2）。结果支持了根据碱形成了不同的钯中间体配合物。使用NaOAc，优先生成[ArPdX（H 2 O）2 ]}复合物，得到肉桂醛2。另一方面，在HN（i -Pr）存在下如图2所示，将产生L型配体[ArPdX（HN（i -Pr ）2（H 2 O）]或[ArPdX（HN（i -Pr ）2（HN（i -Pr）2））]，从而导致在形成3-芳基丙酸酯的1。在过去，协调胺参与很可能是通过分子内形成酯的顺式β-H的消除。
• [EN] 7-HYDROXY-PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AND THEIR USE AS CCR2 RECEPTOR ANTAGONISTS<br/>[FR] COMPOSÉS 7-HYDROXY-PYRAZOLO-[1,5-A] PYRIMIDINE ET LEUR UTILISATION COMME ANTAGONISTES DU RÉCEPTEUR CCR2
  申请人：PROXIMAGEN LTD

  公开号：WO2012041817A1

  公开（公告）日：2012-04-05

  The compounds of formula (I) are antagonists of the CCR2 receptor Wherein R1-7 and A are as defined in the claims.

  式(I)的化合物是CCR2受体的拮抗剂，其中R1-7和A如权利要求中所定义。
• 7-HYDROXY-PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AND THEIR USE AS CCR2 RECEPTOR ANTAGONISTS
  申请人：Boyd Joe William

  公开号：US20130252951A1

  公开（公告）日：2013-09-26

  The compounds of formula (I) are antagonists of the CCR2 receptor Wherein R 1-7 and A are as defined in the claims.

  式(I)的化合物是CCR2受体的拮抗剂，其中R1-7和A如权利要求中所定义。
• CoBr₂(Bpy):  An Efficient Catalyst for the Direct Conjugate Addition of Aryl Halides or Triflates onto Activated Olefins
  作者：Muriel Amatore、Corinne Gosmini、Jacques Périchon

  DOI：10.1021/jo060855f

  日期：2006.8.1

  method devoted to the direct conjugate addition of functionalized aryl compounds onto Michael acceptors is described. The CoBr2(2,2‘-bipyridine) complex appears to be an extremely suitable catalyst for the activation of a variety of aromatic reagents ranging from halides to triflates functionalized by reactive groups. This procedure allows for the synthesis of compounds resulting from 1,4-addition in good

  描述了致力于将官能化的芳基化合物直接共轭加成到迈克尔受体上的有效的钴催化方法。CoBr 2（2,2'-联吡啶）配合物似乎是一种非常合适的催化剂，可用于活化各种芳族试剂，从卤化物到被反应基团官能化的三氟甲磺酸酯。该方法允许以良好的至优异的产率合成由1，4-加成产生的化合物。该原始方法的多功能性代表了使用有机金属试剂的大多数已知方法的简单替代方案。
• 4-Pyrimidone compounds
  申请人：Smith Kline & French Laboratories Limited

  公开号：US04145546A1

  公开（公告）日：1979-03-20

  The compounds are substituted isocytosines which are histamine H.sub.2 -antagonists. Two specific compounds of the present invention are 2-\x9b2-(5-methyl-4-imidazolylmethylthio)-ethylamino!-5-(3-methoxybenzyl)-4-p\n' yrimidone and 2-\x9b2-(5-methyl-4-imidazolylmethylthio)ethylamino!-5-benzyloxy-4-pyrimidone\n' .

  这些化合物是取代的异胞嘧啶，是组胺H.sub.2-拮抗剂。本发明的两种特定化合物是2-β2-(5-甲基-4-咪唑基甲硫基)-乙基氨基-5-(3-甲氧基苄基)-4-吡咯啉酮和2-β2-(5-甲基-4-咪唑基甲硫基)乙基氨基-5-苄氧基-4-吡咯啉酮。